25th November 2021 | Pharma Updates
Freudenberg to bring products next year focussed on fluid-handling space for biopharma
Freudenberg’s parent company Freudenberg Group, has held business relations with customers in India since 1920.
Sun Pharma's Metformin FDC, Glimepiride, Dapagliflozin gets CDSCO approval for trial
The pharma major has received a nod to conduct phase 3 clinical trial.
Covid will put a spotlight on pharma supply chains in Asia, says Fitch Solutions
Fitch Solutions pointed out that the Covid pandemic shaken upstream supply of APIs from China and the manufacturing of finished products in India.
ANG Lifesciences spurts after acquisition
ANG Lifesciences India will buy 2.6 lakh equity shares of ANG Healthcare India for approx 4 cr INR.
First study shows 50% effectiveness of India’s Covid vaccine
The study shows, Covaxin is just 50% against symptomatic Covid after two doses.
Sputnik Light may be available in India by next month, says RDIF
Single-shot Sputnik Light is equivalent to component-1 of Sputnik V which is already in use in India’s Covid vaccination drive.
Uzbekistan invites Indian drug companies to set up manufacturing units
Uzbekistan has asked Indian pharma companies to harness its $1.3 bn drug market by setting up their manufacturing facilities, said Alisher Temirov, Deputy Minister, Pharmaceutical Industry Development of Uzbekistan.
